Spinal Cord Injury Cervical
Oncology·MeSH: Quadriplegia
Prevalence
30.0 / 100K
1 drug in development·1 company·5 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| opc1 | Lineage Cell Therapeutics, Inc. (LCTX) |
Frequently asked questions
How many drugs are in development for Spinal Cord Injury Cervical?
BioSniper tracks 1 drug in development for Spinal Cord Injury Cervical across 1 company.
How many clinical trials target Spinal Cord Injury Cervical?
There are 5 clinical trials targeting Spinal Cord Injury Cervical tracked by BioSniper.
What is the prevalence of Spinal Cord Injury Cervical?
The estimated prevalence of Spinal Cord Injury Cervical is approximately 30.0 per 100,000 population.
Deep-dive into Spinal Cord Injury Cervical
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis